You are here

News

Press Releases

Press Release | January 20, 2017

Davos-Klosters, Switzerland – AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and advance public health, today announced a global stakeholder initiative to optimize the use of diagnostic tests in the fight against antimicrobial resistance (AMR). The initiative comes as current trends project antimicrobial resistance could cause up to 10 million deaths annually by 2050.

Press Release | November 21, 2016

WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, today issued the following statement regarding FDA’s decision not to release at this time a final guidance on oversight of laboratory developed tests:

Press Release | October 17, 2016

WASHINGTON, DC – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), and Andy Fish, executive director of AdvaMedDx, today jointly issued the following statement on the Final Report of the Cancer Moonshot Task Force:

​​​​​